Systemic Epstein-Barr virus-positive t-cell lymphoproliferative disease of childhood with good response to steroid therapy

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoproliferative disease of childhood is a rare disease and has a very fulminant clinical course with high mortality. A 21-month-old female patient was referred to our hospital with a 1 week history of fever and was subsequently diagnosed with systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood. After starting treatment with dexamethasone, she showed early defervescence and improvement of laboratory parameters, and has remained disease-free after stopping steroid treatment, although longer follow-up is necessary. Our report underscores the possibility that this disease entity may be heterogenous in terms of prognosis.

Original languageEnglish
Pages (from-to)e497-e500
JournalJournal of Pediatric Hematology/Oncology
Volume39
Issue number8
DOIs
StatePublished - 2017

Bibliographical note

Publisher Copyright:
© 2017 Wolters Kluwer Health, Inc.

Keywords

  • childhood
  • EBV
  • lymphoproliferative disease
  • steroid
  • T cells

Fingerprint

Dive into the research topics of 'Systemic Epstein-Barr virus-positive t-cell lymphoproliferative disease of childhood with good response to steroid therapy'. Together they form a unique fingerprint.

Cite this